Seizert Capital Partners »

Catalyst Pharmaceutical Partners shares owned by Seizert Capital Partners

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Seizert Capital Partners from 13F filings

Historical chart of Seizert Capital Partners investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Seizert Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Seizert Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $334k 14k 24.76
2020-09-30 $230k 78k 2.97
2020-06-30 $210k 46k 4.61

More positions owned by Seizert Capital Partners

Regeneron Pharmaceuticals (REGN)
JPMorgan Chase & Co. (JPM)
Match Group (MTCH)
LKQ Corporation (LKQ)
United Therapeutics Corporation (UTHR)
Allison Transmission Hldngs I (ALSN)
Expedia Group Com New (EXPE)
Goldman Sachs (GS)
Qualcomm (QCOM)
Wells Fargo & Company (WFC)
NetApp (NTAP)
Berkshire Hathaway Cl B New (BRK.B)
Cigna Corp (CI)
Cisco Systems (CSCO)
Acuity Brands (AYI)

View all positions for Seizert Capital Partners

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Vanguard Capital Management
Deerfield Management Company
Dimensional Fund Advisors
Fundsmith
Bank of America Corporation
American Century Companies
Geode Capital Management
Morgan Stanley
Renaissance Technologies
Vanguard Portfolio Management
Royce & Associates
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners